Question thread · 2 questions
What its policy is on the use of beta interferon in the treatment of multiple sclerosis.
Started with S1W-03393 on 16 Dec 1999; latest 3 Mar 2000. Each later question says it follows up an earlier answer.
Follow-ups
1
Span
78 days
Answered
2 of 2
Asked by
2
The thread, in order
Each answer’s opening lines; open a question for the full text-
To ask the Scottish Executive what its policy is on the use of beta interferon in the treatment of multiple sclerosis.
Susan Deacon, 16 Feb 2000: In 1995, guidance about new drugs for Multiple Sclerosis and clinical advice from the Scottish Medical Advisory Committee was issued to all Health Boards. The guidance asked Health Boards, in consultation with other key interests, to develop and implement local arrangements to manage the entry of these drugs into the … -
What plans it has to ensure that individual health boards are following the Scottish Medical Advisory Committee's guidance about new drugs for multiple sclerosis and clinical advice, issued to all health boards in 1995.
Susan Deacon, 31 Mar 2000: The Scottish Medical Advisory Committee's guidance about new drugs for the treatment of relapsing-remitting multiple sclerosis continues to apply. The implementation of that guidance is a matter for each health board.
How this thread is put together
- Follow-up
- A question whose text says it is “further to the answer to question …” (or reply, response, or asks for a “substantive answer” to an earlier question). The question it names is its parent.
- Several citations
- When a question cites more than one earlier question, the most recent one we hold is used as the parent; the others are listed as “also cites”.
- Thread
- Follow parents back to the first question; every question that leads back to it is in this thread. Branches are shown in date order.